UniProt ID | PARP8_HUMAN | |
---|---|---|
UniProt AC | Q8N3A8 | |
Protein Name | Poly [ADP-ribose] polymerase 8 | |
Gene Name | PARP8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 854 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MGMCSRQERIQKDIDVVIQKSRAEKDCLFADFRYSDSTFTFTYVGGPRSVSYSVHVSEDYPDNTYVSSSENDEDVLVTTEPIPVIFHRIATELRKTNDINCCLSIKSKLQKENGEESRQNSTVEEDSEGDNDSEEFYYGGQVNYDGELHKHPQLEADLSAVREIYGPHAVSLREYGAIDDVDIDLHIDVSFLDEEIAVAWEVIRTEPIIVRLHCSLTQYLNGPVPTVDVFQISTKERFGLGHQLKKIMQTFVTQQWKQSKEKSNCLHNKKLSEKKVKSPLHLFSTLRRSPSYPPPGCGKSKSKLKSEQDGISKTHKLLRRTCSSTVKTDDVCVTKSHRTFGRSLSSDPRAEQAMTAIKSHKLLNRPCPAAVKSEECLTLKSHRLLTRSCSGDPRCEHNTNLKPHKLLSRSYSSNLRMEELYGLKNHKLLSKSYSSAPKSSKTELFKEPNAEGRRLSLTSGLIGILTPSSSSSSQLAPNGAKCIPVRDRGFLVQTIEFAEQRIPVLNEYCVVCDEPHVFQNGPMLRPTVCERELCVFAFQTLGVMNEAADEIATGAQVVDLLVSMCRSALESPRKVVIFEPYPSVVDPNDPQMLAFNPRKKNYDRVMKALDSITSIREMTQAPYLEIKKQMDKQDPLAHPLLQWVISSNRSHIVKLPVNRQLKFMHTPHQFLLLSSPPAKESNFRAAKKLFGSTFAFHGSHIENWHSILRNGLVVASNTRLQLHGAMYGSGIYLSPMSSISFGYSGMNKKQKVSAKDEPASSSKSSNTSQSQKKGQQSQFLQSRNLKCIALCEVITSSDLHKHGEIWVVPNTDHVCTRFFFVYEDGQVGDANINTQEGGIHKEILRVIGNQTATG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MGMCSRQERIQK ---CCCCCHHHHHHH | 28.27 | 27135362 | |
20 | Ubiquitination | DIDVVIQKSRAEKDC HHHHHHCCCHHHCCE | 30.68 | 21890473 | |
20 (in isoform 2) | Ubiquitination | - | 30.68 | 21890473 | |
20 (in isoform 1) | Ubiquitination | - | 30.68 | 21890473 | |
96 | Phosphorylation | IATELRKTNDINCCL HHHHHHHCCCCCCCH | 31.52 | - | |
104 | Phosphorylation | NDINCCLSIKSKLQK CCCCCCHHHHHHHHH | 17.66 | - | |
106 | Ubiquitination | INCCLSIKSKLQKEN CCCCHHHHHHHHHHC | 37.86 | - | |
245 | Ubiquitination | FGLGHQLKKIMQTFV CCCHHHHHHHHHHHH | 33.41 | - | |
257 | Acetylation | TFVTQQWKQSKEKSN HHHHHHHHHHHHHHC | 40.11 | 24468223 | |
278 | Phosphorylation | LSEKKVKSPLHLFST CCHHHCCCHHHHHHH | 35.36 | 28450419 | |
284 | Phosphorylation | KSPLHLFSTLRRSPS CCHHHHHHHHCCCCC | 32.65 | 26074081 | |
285 | Phosphorylation | SPLHLFSTLRRSPSY CHHHHHHHHCCCCCC | 19.56 | 26074081 | |
289 | Phosphorylation | LFSTLRRSPSYPPPG HHHHHCCCCCCCCCC | 16.27 | 30108239 | |
291 | Phosphorylation | STLRRSPSYPPPGCG HHHCCCCCCCCCCCC | 52.06 | 28450419 | |
292 | Phosphorylation | TLRRSPSYPPPGCGK HHCCCCCCCCCCCCC | 24.12 | 30108239 | |
321 | Phosphorylation | THKLLRRTCSSTVKT HHHHHHHHCCCCCCC | 15.42 | 29514088 | |
323 | Phosphorylation | KLLRRTCSSTVKTDD HHHHHHCCCCCCCCC | 28.56 | 23401153 | |
324 | Phosphorylation | LLRRTCSSTVKTDDV HHHHHCCCCCCCCCE | 39.09 | 29514088 | |
325 | Phosphorylation | LRRTCSSTVKTDDVC HHHHCCCCCCCCCEE | 15.10 | 29514088 | |
328 | Phosphorylation | TCSSTVKTDDVCVTK HCCCCCCCCCEEEEC | 32.85 | - | |
332 | ADP-ribosylation | TVKTDDVCVTKSHRT CCCCCCEEEECCCCC | 4.07 | 25043379 | |
335 | Ubiquitination | TDDVCVTKSHRTFGR CCCEEEECCCCCCCC | 24.70 | - | |
343 | Phosphorylation | SHRTFGRSLSSDPRA CCCCCCCCCCCCHHH | 32.74 | 28450419 | |
345 | Phosphorylation | RTFGRSLSSDPRAEQ CCCCCCCCCCHHHHH | 33.66 | 23401153 | |
346 | Phosphorylation | TFGRSLSSDPRAEQA CCCCCCCCCHHHHHH | 57.85 | 28450419 | |
355 | Phosphorylation | PRAEQAMTAIKSHKL HHHHHHHHHHHHHHH | 28.39 | 27486199 | |
358 | Ubiquitination | EQAMTAIKSHKLLNR HHHHHHHHHHHHHCC | 44.00 | - | |
367 | ADP-ribosylation | HKLLNRPCPAAVKSE HHHHCCCCCCCCCCH | 3.02 | 25043379 | |
372 | Sumoylation | RPCPAAVKSEECLTL CCCCCCCCCHHHEEE | 47.63 | - | |
372 | Acetylation | RPCPAAVKSEECLTL CCCCCCCCCHHHEEE | 47.63 | 20167786 | |
372 | Sumoylation | RPCPAAVKSEECLTL CCCCCCCCCHHHEEE | 47.63 | - | |
376 | ADP-ribosylation | AAVKSEECLTLKSHR CCCCCHHHEEECCCE | 2.86 | 25043379 | |
380 | Acetylation | SEECLTLKSHRLLTR CHHHEEECCCEECHH | 38.69 | 20167786 | |
388 | Phosphorylation | SHRLLTRSCSGDPRC CCEECHHCCCCCCCC | 13.85 | - | |
390 | Phosphorylation | RLLTRSCSGDPRCEH EECHHCCCCCCCCCC | 47.69 | 23898821 | |
395 | ADP-ribosylation | SCSGDPRCEHNTNLK CCCCCCCCCCCCCCC | 8.31 | 25043379 | |
405 | Acetylation | NTNLKPHKLLSRSYS CCCCCHHHHHCCCCC | 60.70 | 20167786 | |
410 | Phosphorylation | PHKLLSRSYSSNLRM HHHHHCCCCCCCCCH | 26.45 | 28450419 | |
411 | Phosphorylation | HKLLSRSYSSNLRME HHHHCCCCCCCCCHH | 18.27 | 30001349 | |
412 | Phosphorylation | KLLSRSYSSNLRMEE HHHCCCCCCCCCHHH | 17.63 | 28450419 | |
413 | Phosphorylation | LLSRSYSSNLRMEEL HHCCCCCCCCCHHHH | 31.48 | 28450419 | |
424 | Ubiquitination | MEELYGLKNHKLLSK HHHHHCCHHCHHCCC | 53.28 | - | |
427 | Ubiquitination | LYGLKNHKLLSKSYS HHCCHHCHHCCCCCC | 61.59 | - | |
431 | Ubiquitination | KNHKLLSKSYSSAPK HHCHHCCCCCCCCCC | 54.07 | - | |
434 | Phosphorylation | KLLSKSYSSAPKSSK HHCCCCCCCCCCCCC | 27.41 | 25072903 | |
435 | Phosphorylation | LLSKSYSSAPKSSKT HCCCCCCCCCCCCCC | 40.12 | 24719451 | |
441 | Ubiquitination | SSAPKSSKTELFKEP CCCCCCCCCCHHCCC | 53.78 | - | |
456 | Phosphorylation | NAEGRRLSLTSGLIG CCCCCCEEECCCEEE | 27.99 | 28450419 | |
458 | Phosphorylation | EGRRLSLTSGLIGIL CCCCEEECCCEEEEE | 19.85 | 28450419 | |
459 | Phosphorylation | GRRLSLTSGLIGILT CCCEEECCCEEEEEC | 36.57 | 28450419 | |
466 | Phosphorylation | SGLIGILTPSSSSSS CCEEEEECCCCCCCC | 21.14 | 28450419 | |
560 (in isoform 2) | Phosphorylation | - | 3.25 | 29116813 | |
569 (in isoform 2) | Phosphorylation | - | 7.64 | 29116813 | |
571 (in isoform 2) | Phosphorylation | - | 30.75 | 29116813 | |
607 | Ubiquitination | KNYDRVMKALDSITS CCHHHHHHHHHHCHH | 42.83 | - | |
614 | Phosphorylation | KALDSITSIREMTQA HHHHHCHHHHHHHCC | 20.27 | 29116813 | |
654 | Ubiquitination | SNRSHIVKLPVNRQL CCCCEEEEEECCCCE | 46.61 | - | |
706 | Phosphorylation | SHIENWHSILRNGLV HHHHCHHHHHHCCEE | 18.22 | - | |
753 | Phosphorylation | MNKKQKVSAKDEPAS CCCCCCCCCCCCCCC | 36.31 | 22964224 | |
760 | Phosphorylation | SAKDEPASSSKSSNT CCCCCCCCCCCCCCC | 45.95 | 17525332 | |
767 | Phosphorylation | SSSKSSNTSQSQKKG CCCCCCCCHHHHHHH | 30.05 | 17525332 | |
770 | Phosphorylation | KSSNTSQSQKKGQQS CCCCCHHHHHHHHHH | 43.67 | 17525332 | |
777 | Phosphorylation | SQKKGQQSQFLQSRN HHHHHHHHHHHHHCC | 18.27 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PARP8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PARP8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PARP8_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PARP8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-760; THR-767 ANDSER-770, AND MASS SPECTROMETRY. |